Please enable Javascript
Tsuyoshi Shirakawa, MD, PhD
Tsuyoshi Shirakawa, MD, PhD, of the Oncology Treatment Study Group
Articles by Tsuyoshi Shirakawa, MD, PhD
NAPOLEON-2: Nanoliposomal Irinotecan and Neutropenia in Patients With Pancreatic Cancer
Tsuyoshi Shirakawa, MD, PhD
Pancreatic Cancer
|
March 13, 2025
Dr. Shirakawa highlighted the results of the NAPOLEON-2 trial, including how RWD compare to clinical trial findings.
View More